About this trial
This feasibility study investigates the potential of hypnosis as a complementary therapy for improving attentional deficits and reducing fatigue in patients with neurological conditions such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation approaches. By integrating hypnosis with standard care and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the feasibility, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.
Eligibility criteria
Qualifiers
ICD-10 Diagnosis of stroke, TBI or MS
Admitted to the inpatient and/or outpatient in the Clinic for Neurology and Neurorehabilitation
Age 18 years old or older
Understanding the German language
Disqualifiers
None
Trial design
Treatments tested in this trial
- Intervention Hypnosis